Skip to main content

NAHAR SPINNING MILLS (500296 & NSE) (107.8) (FACE VALUE Rs.5)

Nahar Spinning Mills Limited manufactures and sells yarns and knitted garments primarily in India. The company offers raw white combed, raw white carded/open end, dyed, organic cotton, fair trade cotton, better cotton initiative, melange, gassed/mercerized, compact spun, blended, synthetic/man-made fiber, and cleaner yarns, as well as grindle, space dyed, slub, core spun, high twist, reverse twist, and elitwist yarns. It also provides woolen/cotton hosiery knit-wears and woolen textiles; and T-shirts. The company also exports its products primarily to the United States, the United Kingdom, France, Brazil, Bangladesh, Mauritius, Honduras, Argentina, Colombia, Peru, Chile, the Netherlands, Japan, Canada, Korea, Taiwan, Hong Kong, Singapore, Egypt, and Russia. Nahar Spinning Mills Limited was incorporated in 1980 and is based in Ludhiana, India.
It has an equity base of just Rs.18.03crore that is supported by reserves of around Rs.742.27crore. It has a share book value of Rs.211.
The Promoters hold 73.76% while the investing public holds 26.09% stake in the company.
For Q1FY16, sales have remains flat to Rs.513.06crore. Despite of flat topline & rise in income tax, company has posted net profit of Rs.26.38crore against loss of Rs.11.47crore. Q1FY16 EPS stood at Rs.7.32. It has paid 20% dividend for FY15.
Investors can buy this stock with a stop loss of Rs.99. On the upper side, it will zoom to Rs.135-140 levels in the medium term while stock may zoom up to Rs.190-200 in the long term. Its all-time high rate is Rs.313……
Nahar Spinning Mills Limited manufactures and sells yarns and knitted garments primarily in India. The company offers raw white combed, raw white carded/open end, dyed, organic cotton, fair trade cotton, better cotton initiative, melange, gassed/mercerized, compact spun, blended, synthetic/man-made fiber, and cleaner yarns, as well as grindle, space dyed, slub, core spun, high twist, reverse twist, and elitwist yarns. It also provides woolen/cotton hosiery knit-wears and woolen textiles; and T-shirts. The company also exports its products primarily to the United States, the United Kingdom, France, Brazil, Bangladesh, Mauritius, Honduras, Argentina, Colombia, Peru, Chile, the Netherlands, Japan, Canada, Korea, Taiwan, Hong Kong, Singapore, Egypt, and Russia. Nahar Spinning Mills Limited was incorporated in 1980 and is based in Ludhiana, India.
It has an equity base of just Rs.18.03crore that is supported by reserves of around Rs.742.27crore. It has a share book value of Rs.211.
The Promoters hold 73.76% while the investing public holds 26.09% stake in the company.
For Q1FY16, sales have remains flat to Rs.513.06crore. Despite of flat topline & rise in income tax, company has posted net profit of Rs.26.38crore against loss of Rs.11.47crore. Q1FY16 EPS stood at Rs.7.32. It has paid 20% dividend for FY15.
Investors can buy this stock with a stop loss of Rs.99. On the upper side, it will zoom to Rs.135-140 levels in the medium term while stock may zoom up to Rs.190-200 in the long term. Its all-time high rate is Rs.313……

Comments

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share & market cap of compan

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such as